Email this article Antiviral Activity of Ergoferon against Group A Rotavirus
- Authors: Emelianova A.G.1, Shilovskii I.P.2, Sundukova M.S.2, Khaitov M.R.2, Epshtein O.I.1
-
Affiliations:
- Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
- State Research Center Institute of Immunology, Federal Medical-Biological Agency
- Issue: Vol 161, No 6 (2016)
- Pages: 806-807
- Section: Virology
- URL: https://journals.rcsi.science/0007-4888/article/view/237801
- DOI: https://doi.org/10.1007/s10517-016-3516-x
- ID: 237801
Cite item
Open Access
Access granted
Subscription Access
Abstract
Antiviral activity of Ergoferon was studied in vitro on an experimental model of rotavirus infection in MA-104 cell line. In infected cells treated with Ergoferon, rotavirus titer was shown to decrease by 83 and 90% in comparison with cells treated with solvent used for Ergoferon preparation (p<0.05) and distilled water (p<0.05), respectively. These findings demonstrate high anti-rotavirus activity of Ergoferon.
About the authors
A. G. Emelianova
Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
Author for correspondence.
Email: agemelianova@gmail.com
Russian Federation, Moscow
I. P. Shilovskii
State Research Center Institute of Immunology, Federal Medical-Biological Agency
Email: agemelianova@gmail.com
Russian Federation, Moscow
M. S. Sundukova
State Research Center Institute of Immunology, Federal Medical-Biological Agency
Email: agemelianova@gmail.com
Russian Federation, Moscow
M. R. Khaitov
State Research Center Institute of Immunology, Federal Medical-Biological Agency
Email: agemelianova@gmail.com
Russian Federation, Moscow
O. I. Epshtein
Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
Email: agemelianova@gmail.com
Russian Federation, Moscow
